Gibbs Michael Terrence

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$11,920.00
Insider Sells Quantity
12
Insider Sells Sum
$99,184.06

Insider Activity of Gibbs Michael Terrence

The largest purchase of all time was on 2017-06-06 and amounted to 2000 shares of T2 Biosystems, Inc. for $7,020.

The largest sale of all time was on 2019-02-11 and amounted to 6010 shares of T2 Biosystems, Inc. for $20,194.

Biography of Gibbs Michael Terrence

No biography is available at this moment.

2023-03-28SaleT2 Biosystems, Inc.
TTOO
General Counsel
239
<0.0001%
$0.48$115-5.51%
2023-02-28SaleT2 Biosystems, Inc.
TTOO
General Counsel
1,585
<0.0001%
$0.59$935-5.51%
2023-02-22SaleT2 Biosystems, Inc.
TTOO
General Counsel
2,145
<0.0001%
$0.65$1,394-5.51%
2022-04-07PurchaseT2 Biosystems, Inc.
TTOO
General Counsel
10,000
0.0055%
$0.49$4,900-81.3%
2021-03-25SaleT2 Biosystems, Inc.
TTOO
General Counsel
8,758
0.0055%
$1.56$13,662-46.55%
2021-02-23SaleT2 Biosystems, Inc.
TTOO
General Counsel
7,280
0.0046%
$2.06$14,997-54.34%
2020-02-24SaleT2 Biosystems, Inc.
TTOO
General Counsel
5,808
0.0084%
$0.82$4,763+55.15%
2020-02-11SaleT2 Biosystems, Inc.
TTOO
General Counsel
3,200
0.0044%
$0.77$2,464+52.63%
2020-02-03SaleT2 Biosystems, Inc.
TTOO
General Counsel
3,283
0.0052%
$0.88$2,889+52.61%
2019-02-11SaleT2 Biosystems, Inc.
TTOO
General Counsel
6,010
0.0134%
$3.36$20,194-45%
2019-02-01SaleT2 Biosystems, Inc.
TTOO
General Counsel
3,640
0.008%
$3.47$12,631-45.22%
2019-01-31SaleT2 Biosystems, Inc.
TTOO
General Counsel
1,878
0.0041%
$3.35$6,291-43.57%
2018-02-09SaleT2 Biosystems, Inc.
TTOO
General Counsel
4,404
0.0122%
$4.28$18,849+46.03%
2017-06-06PurchaseT2 Biosystems, Inc.
TTOO
General Counsel
2,000
0.0066%
$3.51$7,020+24.93%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.